α-Gal Nanoparticles in CNS Trauma: I. In Vitro Activation of Microglia Towards a Pro-Healing State
- 15 December 2023
- journal article
- research article
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 21 (3) , 409-419
Abstract
Background: Macrophages and microglia play critical roles after spinal cord injury (SCI), with the pro-healing, anti-inflammatory (M2) subtype being implicated in tissue repair. We hypothesize that promoting this phenotype within the post-injured cord microenvironment may provide beneficial effects for mitigating tissue damage. As a proof of concept, we propose the use of nanoparticles incorporating the carbohydrate antigen, galactose-α-1,3-galactose (α-gal epitope) as an immunomodulator to transition human microglia (HMC3) cells toward a pro-healing state. Methods: Quiescent HMC3 cells were acutely exposed to α-gal nanoparticles in the presence of human serum and subsequently characterized for changes in cell shape, expression of anti or pro-inflammatory markers, and secretion of phenotype-specific cytokines. Results: HMC3 cells treated with serum activated α-gal nanoparticles exhibited rapid enlargement and shape change in addition to expressing CD68. Moreover, these activated cells showed increased expression of anti-inflammatory markers like Arginase-1 and CD206 without increasing production of pro-inflammatory cytokines TNF-α or IL-6. Conclusion: This study is the first to show that resting human microglia exposed to a complex of α-gal nanoparticles and anti-Gal (from human serum) can be activated and polarized toward a putative M2 state. The data suggests that α-gal nanoparticles may have therapeutic relevance to the CNS microenvironment, in both recruiting and polarizing macrophages/microglia at the application site. The immunomodulatory activity of these α-gal nanoparticles post-SCI is further described in the companion work (Part II). Graphical abstract Resting microglia subjected to α-gal nanoparticle treatment in the presence of anti-Gal (found in serum) become activated and exhibit pro-healing phenotypic markers (Arginase-1, CD206) and secrete VEGF. Expression of pro-inflammatory markers (IL-6, TNF-α) was concomitantly reduced.Keywords
Funding Information
- Indiana Clinical and Translational Sciences Institute (204200)
- National Institute of Neurological Disorders and Stroke (1R21NS115094-01)
This publication has 48 references indexed in Scilit:
- Anti‐Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefitsImmunology, 2013
- Comparison of polarization properties of human adult microglia and blood‐derived macrophagesGlia, 2012
- Rapid Recruitment and Activation of Macrophages by Anti-Gal/α-Gal Liposome Interaction Accelerates Wound HealingThe Journal of Immunology, 2011
- Endogenous expression of interleukin‐4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injuryJournal of Neuroscience Research, 2010
- Accelerated healing of skin burns by anti-Gal/α-gal liposomes interactionBurns, 2010
- IL-10 promotes neuronal survival following spinal cord injuryExperimental Neurology, 2009
- Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal CordThe Journal of Neuroscience, 2009
- Microglial Physiology: Unique Stimuli, Specialized ResponsesAnnual Review of Immunology, 2009
- Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humansImmunology Today, 1993
- Regulation of macrophage phagocytosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986